E1	Modifier:T1 Modifies:T64
E2	Or:T2 Arg:E1 Arg2:E3
E3	Modifier:T3 Modifies:T64
E4	Condition:T4 Name:T64 Polarity:T63
E6	Observation:T6 Name:T66
E7	Eq-Comparison:T7 Value:T67 Value2:T106
E8	Condition:T8 Name:T69 Polarity:T68
E9	Temporal-Connection:T9 Arg:E10
E10	Study:T10
E11	Eq-Comparison:T11 Temporal-Period:T70
E13	Procedure:T13 Name:T71 Temporality:E11
E14	Exception:T14 From:E13 Except:E16
E15	Eq-Comparison:T15 Temporal-Period:T74
E16	Procedure:T16 Name:T110 Temporality:E15 Minimum-Count:E67
E17	Condition:T17 Name:T111
E18	Eq-Comparison:T18 Temporal-Period:T75
E19	Drug:T19 Name:T76 Temporality:E18
E20	Or:T20 Arg:E19 Arg2:E21
E21	Drug:T21 Name:T77 Temporality:E18
E22	Modifier:T22 Modifies:T78
E23	Condition:T23 Name:T78
E24	Procedure:T24
E25	Drug:T25 Name:T79
E26	Modifier:T26 Modifies:T79
E27	Or:T27 Arg:E26 Arg2:E28
E30	Modifier:T30 Modifies:T82
E31	Procedure:T31 Name:T82
E32	Eq-Comparison:T32 Temporal-Period:T83
E33	Other:T33 Is-Other:E34
E34	Condition:T34 Name:T84 Temporality:E32 Temporality2:E35
E35	Eq-Comparison:T35 Operator:T85 Temporal-Period:T86 Value:T87 Temporal-Unit:T81
E36	Condition:T36 Name:T88
E37	Modifier:T37 Modifies:T90
E38	Or:T38 Arg:E37 Arg2:E39
E39	Modifier:T39 Modifies:T90
E40	Condition:T40 Name:T90
E41	Modifier:T41 Modifies:T90
E42	Eq-Comparison:T42 Temporal-Period:T91
E43	Procedure:T43 Temporality:E42
E44	Modifier:T44 Modifies:E43
E45	Condition:T45 Name:T92
E46	Or:T46 Arg:E45 Arg2:E47
E47	Condition:T47 Name:T93
E48	Condition:T48 Name:T95
E49	Assertion:T49 Asserted:E48
E50	Assertion:T50 Asserted:E74
E51	Modifier:T51 Modifies:T96
E52	Procedure:T52 Name:T96 Duration:E57
E53	Temporal-Connection:T53 Arg:E52 Arg2:E55
E54	Study:T54 Study-Of:E55
E55	Procedure:T55
E56	And:T56 Arg:E55 Arg2:E57
E57	Eq-Comparison:T57 Operator:T97 Value:T98 Temporal-Unit:T99
E58	Temporal-Connection:T58 Arg:E57 Arg2:E59
E59	Eq-Comparison:T59 Temporal-Recency:T100
E60	Study:T60 Study-Of:E61
E61	Procedure:T61 Temporality:E59
E62	Modifier:T62 Modifies:T64
E5	Condition:T5 Name:T65
E65	Observation:T104 Name:T105 Eq-Comparison:E7
E12	Condition:T12 Name:T107
E66	Condition:T108 Name:T72
E67	Eq-Comparison:T109 Value:T73
E68	Modifier:T112 Modifies:T76
E69	Exception:T113 From:E24 Except:E25
E28	Modifier:T28 Modifies:T79
E29	Negation:T29 Negates:E31
E70	Assertion:T80 Asserted:E29
E71	Exception:T114 From:E34 Except:E36 Except2:E40
E72	Modifier:T89 Modifies:T88
E73	Or:T116 Arg:T115 Arg2:T94
E74	Negation:T117 Negates:E52
E63	Modifier:T101 Modifies:T65
T1	Modifier 53 48	recurrent
T2	Or 56 51	or
T3	Modifier 74 69	metastasis breast
T4	Condition 81 76	cancer
T6	Observation 182 169	Eastern Cooperative Oncology Group
T7	Eq-Comparison 219 201	0 or 1
T8	Condition 252 231	organ function
T9	Temporal-Connection 312 286	prior to
T10	Study 322 296	study
T11	Eq-Comparison 372 340	History
T13	Procedure 397 363	therapy
T14	Exception 426 390	exception
T15	Eq-Comparison 439 403	prior
T16	Procedure 456 420	hormonal regimen
T17	Condition 464 428	MBC
T18	Eq-Comparison 483 443	History
T19	Drug 517 477	tyrosine kinase inhibitors
T20	Or 520 480	or
T21	Drug 540 500	monoclonal antibody
T22	Modifier 551 511	breast
T23	Condition 558 518	cancer
T24	Procedure 575 535	treatment
T25	Drug 604 562	trastuzumab
T26	Modifier 631 587	neo-adjuvant
T27	Or 634 590	or
T30	Modifier 720 672	systemic
T31	Procedure 733 685	chemotherapy
T32	Eq-Comparison 751 699	History
T33	Other 760 708	other
T34	Condition 771 719	malignancy
T35	Eq-Comparison 796 743	within the last 5 years
T36	Condition 819 764	carcinoma
T37	Modifier 860 803	basal cell carcinoma
T38	Or 863 806	or
T39	Modifier 877 820	squamous cell
T40	Condition 887 830	carcinoma
T41	Modifier 899 842	skin
T42	Eq-Comparison 924 867	previously
T43	Procedure 932 875	treated
T44	Modifier 953 896	curative intent
T45	Condition 972 911	Pregnant
T46	Or 975 914	or
T47	Condition 985 924	lactating
T48	Condition 1022 959	childbearing
T49	Assertion 1032 969	potential
T50	Assertion 1045 982	unwilling to
T51	Modifier 1070 1005	highly-effective
T52	Procedure 1084 1019	contraception
T53	Temporal-Connection 1091 1026	during
T54	Study 1104 1039	study
T55	Procedure 1114 1049	treatment
T56	And 1118 1053	and
T57	Eq-Comparison 1141 1075	at least 7 months
T58	Temporal-Connection 1147 1081	after
T59	Eq-Comparison 1156 1090	last
T60	Study 1170 1104	study
T61	Procedure 1180 1114	treatment
T63	Polarity 43 38	positive
T64	Condition-Name 81 76	cancer
T66	Observation-Name 182 169	Eastern Cooperative Oncology Group
T67	Eq-Value 213 196	0
T68	Polarity 237 216	Adequate
T69	Condition-Name 252 231	organ function
T70	Eq-Temporal-Period 372 340	History
T71	Procedure-Name 397 363	therapy
T72	Condition-Name 405 371	MBC
T73	Eq-Value 433 397	one
T74	Eq-Temporal-Period 439 403	prior
T75	Eq-Temporal-Period 483 443	History
T76	Drug-Name 517 477	tyrosine kinase inhibitors
T77	Drug-Name 540 500	monoclonal antibody
T78	Condition-Name 558 518	cancer
T79	Drug-Name 604 562	trastuzumab
T82	Procedure-Name 733 685	chemotherapy
T83	Eq-Temporal-Period 751 699	History
T84	Condition-Name 771 719	malignancy
T85	Eq-Operator 778 726	within
T86	Eq-Temporal-Period 787 735	last
T87	Eq-Value 790 737	5
T88	Condition-Name 819 764	carcinoma
T90	Condition-Name 887 830	carcinoma
T91	Eq-Temporal-Period 924 867	previously
T92	Condition-Name 972 911	Pregnant
T93	Condition-Name 985 924	lactating
T94	Life-Stage-And-Gender 1006 943	women
T95	Condition-Name 1022 959	childbearing
T96	Procedure-Name 1084 1019	contraception
T97	Eq-Operator 1131 1066	at least
T98	Eq-Value 1134 1068	7
T99	Eq-Temporal-Unit 1141 1075	months
T100	Eq-Temporal-Recency 1156 1090	last
T62	Modifier 34 29	HER2
T5	Condition 124 115	disease
T65	Condition-Name 124 115	disease
T104	Observation 189 174	ECOG
T105	Observation-Name 189 174	ECOG
T106	Eq-Value 219 201	1
T12	Condition 389 355	cancer
T107	Condition-Name 389 355	cancer
T108	Condition 405 371	MBC
T109	Eq-Comparison 433 397	one
T110	Procedure-Name 456 420	hormonal regimen
T111	Condition-Name 464 428	MBC
T112	Modifier 490 450	HER
T113	Exception 592 550	except
T28	Modifier 643 599	adjuvant
T29	Negation 703 655	unable
T80	Assertion 703 655	unable
T81	Eq-Temporal-Unit 796 743	years
T114	Exception 805 750	except
T89	Modifier 837 782	situ of cervix
T115	Life-Stage-And-Gender 991 930	women
T116	Or 996 933	or
T117	Negation 1045 982	unwilling to
T101	Modifier 116 107	measurable
A1	Temporal-Connection-Type-Value E9 before
A2	Assertion-Type-Value E49 hypothetical
A3	Assertion-Type-Value E50 hypothetical
A4	Temporal-Connection-Type-Value E53 during
A5	Temporal-Connection-Type-Value E58 after
A6	Polarity-Value T63 positive
A7	Observation-Type-Value T66 clinical-score
A8	Polarity-Value T68 normal
A9	Eq-Temporal-Period-Value T70 past
A10	Eq-Temporal-Period-Value T74 past
A11	Eq-Temporal-Period-Value T75 past
A12	Eq-Temporal-Period-Value T83 past
A13	Eq-Operator-Value T85 LTEQ
A14	Eq-Temporal-Period-Value T86 past
A15	Eq-Temporal-Period-Value T91 past
A16	Life-Stage-And-Gender-Type T94 female
A17	Eq-Operator-Value T97 GTEQ
A18	Eq-Temporal-Unit-Value T99 month
A22	Assertion-Type-Value E70 hypothetical
A23	Eq-Temporal-Unit-Value T81 year
A24	Life-Stage-And-Gender-Type T115 female
A19	Eq-Temporal-Recency-Value T100 most-recent-time
R2	Abbrev-Of Arg1:E65 Arg2:E6
R3	Treatment-For Arg1:E13 Arg2:E12
R4	Treatment-For Arg1:E13 Arg2:E66
R5	Treatment-For Arg1:E16 Arg2:E17
R6	Treatment-For Arg1:E19 Arg2:E23
R7	Treatment-For Arg1:E21 Arg2:E23
R8	Using Arg1:E24 Arg2:E19
R9	Using Arg1:E24 Arg2:E21
R10	Treatment-For Arg1:E24 Arg2:E23
R11	Treatment-For Arg1:E43 Arg2:E40
R12	If-Then Arg1:E47 Arg2:T115
R13	If-Then Arg1:T94 Arg2:E48